Delivery Order SPE2DE24D0013-SPE2D625F3HTL
- Not listed
- The Defense Department's Medical Supply Chain awarded a $25,920 firm fixed-price delivery order to Cepheid Inc. on September 9, 2025, with an ultimate completion date of September 16, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions from the Sunnyvale, California-based manufacturer, likely supporting testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection across federal healthcare systems. This award carries...
- The U.S. Department of Defense's Medical Supply Chain awarded a $13.6K firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer, likely supporting COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities across military healthcare systems. The award carries no...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by September 17, 2025, and carries no set-aside designation. The contract nomenclature indicates the order involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial...
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance completion targeted for September 16, 2025. The contract contains no set-aside designation and represents a...
- The U.S. Defense Department's Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 2, 2025. This delivery order, designated 4569302270 for XPCOV2/FLU/RSV-10 testing solutions, is scheduled for completion by September 9, 2025, with work performed at the contractor's Sunnyvale facility. The award carries no small business set-aside designation and represents part of...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, received a $7,480 firm fixed-price delivery order from the Medical Supply Chain (Defense) on September 9, 2025, with an ultimate completion date of September 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves the procurement of molecular diagnostic solutions, specifically test kits and related supplies for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award...
- The U.S. Department of Defense's Medical Supply Chain awarded a $3,272 firm fixed-price delivery order to Cepheid Inc. on September 12, 2025, with an ultimate completion date of September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus detection. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and test kits, will fulfill...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F3HTLDelivery Order
The U.S. Defense Logistics Agency, acting under the Medical Supply Chain portfolio, awarded a $9,520 firm fixed-price delivery order to Cepheid Inc. on September 12, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, supports molecular diagnostic testing capabilities and is being performed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside designation and represents a continuation of the federal government's ongoing procurement of diagnostic solutions from Cepheid, a leading manufacturer of molecular diagnostic systems and test kits specializing in infectious disease detection. This delivery order likely relates to Cepheid's broader federal contract portfolio with the Veterans Administration and Defense Health Agency, where the company provides GeneXpert diagnostic systems, reagents, and test kits for detecting COVID-19, influenza, respiratory syncytial virus (RSV), and other conditions across federal healthcare networks. Cepheid currently operates under two significant VA Indefinite Delivery/Indefinite Quantity contracts valued at $32.8 million and $2.5 million respectively, which serve as the framework for ongoing molecular diagnostic procurement. The modest delivery order value of $9.52K reflects a specific, time-sensitive requirement for diagnostic supplies or services to support military healthcare operations or logistics readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 9/12/25 |